Concepedia

Radiation dose distributions in normal tissue adjacent to tumors containing (131)I or (90)Y: the potential for toxicity.

Richard Sparks, Eric A. Crowe, Franklin C. Wong, Richard E. Toohey, Jeffry A. Siegel

PubMed · 2002 · 21 citations · 6 references

Abstract

This study showed that when absorbed doses to tumors are large, the absorbed dose to adjacent tissues can also be large, potentially causing unexpected toxicities.

References

6

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of Zevalin™ radioimmunotherapy for low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma

Gregory A. Wiseman, Christine A. White, Richard Sparks et al. · Critical Reviews in Oncology/Hematology · 2001 · 183 citations

, , +9

Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.

Mark Kaminski, L.M. Fig, Kenneth Zasadny et al. · Journal of Clinical Oncology · 1992 · 155 citations

Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.

Robert T. OʼDonnell, Sally J. DeNardo, A. Yuan et al. · PubMed · 2001 · 56 citations

Law and order of radiation sensitivity. Absolute versus relative.

P. Rubin · PubMed · 1989 · 25 citations

, , +9

Dosimetry in radionuclide therapies with 90Y-conjugates: the IEO experience.

Marta Cremonesi, Mahila Ferrari, Marco Chinol et al. · PubMed · 2000 · 17 citations

, , +18